Intelligence

Market expertise, business context, and rigorous analytics

Hyper-focused market intelligence

Our Intelligence Services

At Spherix, the report is only part of the deliverable. Our insights are customized to your business needs and we thrive on delivering not just data, but context. Our experts provide input and interpretation of the findings to finely tune the final reports.

Prepping for the pipeline

Market Dynamix™ is an independent service providing analysis of markets anticipated to experience a paradigm shift within the next three to five years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents and select KOLs.

Sample Size and Frequency

Annual report (n=100-200 physicians, n=25-50 patients)

Qualitative interviews (n=6-8 physicians, n=2-3 KOLs)

Trending market evolution

RealTime Dynamix™ is an independent service providing strategic guidance through quarterly or semiannual reports, which include market trending and a fresh infusion of event-driven and variable content with each wave. The reports provide an unbiased view of the competitive landscape within rapidly evolving specialty markets, fueled by robust HCP primary research and our in-house team of experts.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

US: quarterly report (n=100-200 respondents)

EU5: semiannual report (n=250 respondents)

Canada: semiannual report (n=50 respondents)

Benchmarking new brand performance

Launch Dynamix™ is an independent service providing monthly benchmarking of newly launched products for the first eighteen months of commercial availability, augmented by a quarterly deep dive into promotional activity, barriers to uptake, and patient types gravitating to the launch brand.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of physicians “in the trenches” recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents.

Sample Size and Frequency

Monthly KPI benchmarking (n=75 physicians)

Quarterly report (n=75 physicians)

Quarterly qualitative interviews (n=8 physicians)

Exploring the patient journey

RealWorld Dynamix™ is an independent, data-driven service unveiling real patient management patterns through rigorous analysis of large-scale patient chart audits. Insights reveal the “why” behind treatment decisions, include year over year trending to quantify key aspects of market evolution, and integrate specialists’ attitudinal & demographic data to highlight differences between stated and actual treatment patterns.

Report Methodology: Insights are based on patient level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with their rationale for treatment choices.

Sample Size and Frequency

US: annual patient chart audit (n=1,000 charts, n=200 physicians)

EU5: annual patient chart audit (n=1,250 charts, n=250 physicians)

Gauging impact of disruptive events

Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

Report cadence and deliverable depend upon current event/topic being evaluated.

Let us help you find the service you need

My role is in...

Market Research / Insights
01 –
On-going, unbiased brand and class trending of KPIs in swiftly evolving markets via RealTime Dynamix.
02 –
Robust patient chart audits capturing data not available in claims via RealWorld Dynamix.
03 –
Spherix is a thought partner, helping you answer questions, not just giving you data.
04 –
Our resources should be the foundation of your market research plan.
05 –
You do your brand, let us do the market
Business Development
01 –
You need reliable data fast, often we have it on the shelf. Because our coverage is so broad, we have the ability to pull data from multiple reports to give you a concise overview of the opportunity at hand.
02 –
Because we are so focused, we are the go-to firm for understanding pipeline opportunities and market expansion opportunities in the areas we cover.
03 –
We understand the negotiating process – we can identify your levers (and theirs as well).
04 –
We are independent – both sides can be assured that our data is unbiased and based on solid research.
05 –
We are nimble, we can move as quickly as you do.
Competitive Intelligence
01 –
Our independent, comprehensive coverage of key markets.
02 –
Our timing from fieldwork to publication, ensuring you are the first to see new trends emerging.
03 –
Unparalleled understanding of the markets we cover means we are asking the right questions and giving you context along with the findings.
Financial Analyst / C-Suite
01 –
Trust that our data is independent and widely referenced by company leaders and the investment community.
02 –
Trust that, because we intimately know the markets we focus on, we cover and give context to the real issues that are influencing market shifts.
03 –
Trust that our research methods rely on robust samples with the right audience, giving you confidence in the trends we publish.
Medical Affairs / Clinical Development
01 –
Our patient chart audits (RealWorld Dynamix) help you understand how clinical trial populations compare to real patients with the condition, helping you identify important secondary endpoints that will allow for differentiation in increasingly competitive markets.
02 –
Market Dynamix reports blend KOL and clinician opinion to highlight unmet needs, what attributes are most desired in new therapeutics, and what data is needed to support early adoption and optimization of an asset.
Product Marketing / Agency
01 –
As an independent source with deep market understanding, we are trusted and widely used among all key stakeholders – Pharma companies, KOLs & Professional Organizations, Patient Advocacy Groups, Financial Analyst firms, Managed Care Organizations.
02 –
Unbiased in our comparative coverage of brands.
03 –
Ability to look at our data through the lens of your brand and quickly identify unique threats and opportunities via RealTime Dynamix.
04 –
Launch Dynamix provides granular tracking of your brand for the first 18 months of launch and benchmarks your success to those of your competitors.
05 –
Our patient chart audits (RealWorld Dynamix) help you develop patient profiles and understand where you win, where you should be winning, and where you lose.

Talk to an expert